Barraquer–Simons syndrome

From WikiMD's Wellnesspedia

(Redirected from Cephalothoracic lipodystrophy)

Barraquer–Simons syndrome is a rare form of lipodystrophy that begins in childhood. It is characterized by the loss of subcutaneous fat in the face and upper body, which often leads to an appearance of premature aging.

Symptoms[edit | edit source]

The primary symptom of Barraquer–Simons syndrome is the progressive loss of subcutaneous fat from the face and upper body. This often begins in the face and neck, and then progresses to the shoulders, arms, and chest. Other symptoms can include glaucoma, cataracts, and diabetes mellitus.

Causes[edit | edit source]

The exact cause of Barraquer–Simons syndrome is unknown. However, it is believed to be a genetic disorder, as it often runs in families. Some researchers believe that it may be caused by mutations in the AGPAT2 or BSCL2 genes, but this has not been definitively proven.

Diagnosis[edit | edit source]

Diagnosis of Barraquer–Simons syndrome is based on the characteristic symptoms and a physical examination. Genetic testing may also be performed to look for mutations in the AGPAT2 or BSCL2 genes.

Treatment[edit | edit source]

There is currently no cure for Barraquer–Simons syndrome. Treatment is focused on managing the symptoms and can include liposuction to remove excess fat, insulin therapy for diabetes, and surgery for glaucoma and cataracts.

Prognosis[edit | edit source]

The prognosis for individuals with Barraquer–Simons syndrome varies. Some individuals may have a normal lifespan, while others may have a shortened lifespan due to complications such as diabetes and heart disease.

See also[edit | edit source]


Barraquer–Simons syndrome Resources

Find a healthcare provider anywhere in the world quickly and easily!

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Admin, Prab R. Tumpati, MD